MARKETS / NYSE / CNO

NYSE · ACCIDENT & HEALTH INSURANCE · LARGE CAP

CNO Financial Group, Inc. CNO

18 fiscal years on record · USD · FY2025 reported · SEC filings only

13 YEARS OF DIVIDEND GROWTH

Revenue

$4.5B

▲ 0.9% YoY

Net income

$229.3M

▼ 45.5% YoY

In brief

What this company does

CNO Financial Group, Inc. operates a group of insurance companies that develop, market, and administer health insurance, annuity, individual life insurance, and other insurance and financial services products. As of December 31, 2025, it had total assets of $38.8 billion and shareholders' equity of $2.6 billion. For the year ended December 31, 2025, it had revenues of $4.5 billion and net income of $229.3 million. As of December 31, 2025, it employed approximately 3,300 full-time associates, nearly all of whom are located in the United States. The company views its operations as three insurance product lines—annuity, health, and life—and the investment and fee income segments. CNO became the successor to Conseco, Inc., its predecessor, an Indiana corporation organized in 1979, in a bankruptcy reorganization effective September 10, 2003.

Written from the business description in CNO Financial Group, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 24 February 2026. Every sentence was checked against that document before publication.

Growth

USD 4.5B

Revenue, FY2025 · full 18-year series below

Revenue $B Net income $B

FY2025 · Revenue 4.5 · Net income 0.2

Compound annual growth

Revenue

+7.9%

+3.3%

+1.6%

+0.6%

Net income

−28.6%

−5.3%

−1.6%

−0.3%

EPS, diluted

−24.6%

+1.7%

+5.2%

+6.9%

Dividend / share

+6.8%

+7.3%

+9.5%

Returned to shareholders

+16.9%

+4.1%

−0.6%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at +3.3% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

5 cents

of every revenue dollar became profit

Operating margin Net margin

FY2025 · Operating 12.3% · Net 5.1%

ROE

FY2025 · ROE 8.9%

Gross margin—

Operating margin12.3%

Net margin5.1%

Return on assets0.6%

EBITDAUSD 871.7M

Each USD of equity produced 9 cents of profit this year.

Cash & shareholders

USD 386.0M

returned in FY2025 · dividends + net buybacks

Net buybacks $M Dividends $M

FY2025 · Dividends 66.2 · Net buybacks 319.8

Dividends paidUSD 66.2M

Net buybacksUSD 319.8M

Share of profit168.3%

Consecutive raises13 years

USD 66.2M in dividends and USD 319.8M in buybacks — 168% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 38.8B

EquityUSD 2.6B

CashUSD 983.5M

Gross debtUSD 1.3B

Net debtUSD 352.1M

Net debt stands at 13% of equity.

The 18-year record

18 fiscal years

Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Revenue $B	4.5	4.4	4.1	3.6	4.1	3.8	4.0	4.3	4.3	4.0	3.8	4.1	4.5	4.3	4.1	4.1	4.3	4.2
Operating income $B	0.6	0.6	0.5	0.5	0.5	0.5	0.4	0.4	0.5	·	·	·	·	·	·	·	·	·
EBITDA $B	0.9	0.8	0.7	0.7	0.8	0.8	0.6	0.7	0.7	·	·	·	·	·	·	·	·	·
Income tax $B	0.1	0.1	0.1	0.2	0.2	0.0	−0.1	0.1	0.3	−0.0	0.1	0.1	−0.2	−0.1	−0.0	−0.0	0.1	0.0
Net income $B	0.2	0.4	0.3	0.6	0.6	0.3	0.4	−0.3	0.2	0.4	0.3	0.1	0.5	0.2	0.3	0.2	0.1	−1.1
EPS, diluted $	2.30	3.89	2.40	5.36	4.35	2.11	2.61	−1.90	1.02	2.01	1.39	0.24	2.06	0.83	1.15	0.84	0.45	−6.13
Dividend / sh $	0.67	0.63	0.59	0.55	0.51	0.47	0.43	0.39	0.35	0.31	0.27	0.24	0.11	0.06	·	·	·	·
Payout %	29	16	25	10	12	22	16	−21	34	15	19	99	5	6	0	0	·	·
ROE %	8.9	17.8	13.9	23.1	12.4	5.9	10.2	−7.7	3.8	8.3	6.1	1.1	9.6	4.6	8.0	7.0	3.7	−69.5
Shares out B	0.09	0.10	0.11	0.11	0.12	0.14	0.15	0.16	0.17	0.17	0.18	0.20	0.22	0.22	0.24	0.25	0.25	·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance

Company facts, as filed

How we verify · 0 failures in 53 reconciliationsAUDITED

Reconciled in 18 of 19 fiscal years. 4 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures

ActivityAccident & Health Insurance

Listed onNYSE

Incorporated inDelaware

Fiscal year endsDecember 31

Data on record since2008